By SIMON CONSTABLE
The COVID-19 pandemic may have torpedoed one of corporate America’s favorite activities: Buying back their own shares.
Since the end of the financial crisis a decade ago, each year the companies in the S&P 500 index have spent hundreds of billions of dollars conducting stock buybacks.
But this year the COVID-19 virus will likely put an enormous dent in those programs. Read more here.
The COVID-19 pandemic may have torpedoed one of corporate America’s favorite activities: Buying back their own shares.
Since the end of the financial crisis a decade ago, each year the companies in the S&P 500 index have spent hundreds of billions of dollars conducting stock buybacks.
But this year the COVID-19 virus will likely put an enormous dent in those programs. Read more here.